Horizon Europe: What opportunities for the MedTech sector?
Horizon Europe is the EU’s main funding programme for research and innovation, benefiting from a budget of € 95.5 billion for 2021-2027.
Horizon Europe is divided into 3 pillars and 1 transversal pillar:
- Pillar I aims to increase the EU’s global competitiveness by supporting frontier research, funding fellowships and exchanges for researchers, and investing in world-class research infrastructures.
- Pillar II supports research in areas of societal change through 6 thematic clusters including health.
- Pillar III aims to make the EU a leader in market-creating innovation.
- The transversal pillar aims to increase support to EU member states in upgrading their national research and innovation potential
The Innovative Health Initiative (IHI)
The IHI is the biggest public-private partnership dedicated to health research and innovation worldwide. It gathers the European Union and the European life science industries, namely EFPIA, including Vaccines Europe, COCIR, EuropaBio and MedTech Europe. By bringing diverse sectors together, this cross-sectoral partnership is an opportunity to respond better to health needs.
The medical technology industry can participate in the IHI through collaborative research and innovation projects or by becoming contributing partners.
Learn more about IHI here.
The Health Cluster
The Health Cluster is dedicated to developing health technologies, mitigating health risks, and improving the cost-effectiveness of public health systems. It aims to prevent diseases and develop more effective therapies using personalised medicine approaches and digital health technologies.
The medical technology industries can participate in the Health Cluster through collaborative research and innovation projects, by applying to calls for proposals.
The Marie Sklodowska Curie Actions (MSCA)
The MSCA are the EU programme dedicated to doctoral education and postdoctoral training for researchers. It offers five types of funding: the Doctoral Networks, the Postdoctoral Fellowships, the Staff Exchanges, COFUND, and the MSCA and Citizens.
The MSCA can bring exposure to the medical technology industries, through mobility across borders and foster the gain of new knowledge and skills with training programmes, collaboration, and knowledge transfer.
The European Innovation Council (EIC)
The EIC is the EU programme dedicated to identifying, developing, and scaling up breakthrough technologies and innovations. It offers funding opportunities through the EIC Pathfinder, the EIC Transition, and the EIC Accelerator.
In the health sector, the European Innovation Council supports emerging technologies and helps develop breakthrough solutions to critical societal challenges such as pandemics and population ageing.
The EU-Africa Global Health Partnership (EDCTP3)
The EU-Africa Global Health Partnership is the 3rd programme of the European & Developing Countries Clinical Trials Partnership (EDCTP3) established under Horizon Europe. It gathers 14 European and 16 African countries and targets ten areas of unmet medical need, like HIV, neglected infectious diseases, antimicrobial resistance, and climate crisis-related infectious diseases.
Medical technology industries can participate in the EDCTP3 through collaborative clinical research and fellowships programmes or by becoming contributing partners.
The EU Mission on Cancer
The Mission on Cancer aims to improve the quality of life of people affected by cancer, either patients or their families, through prevention and cure.
The Mission is active in five areas: understanding of cancer, prevention, diagnosis and treatment, quality of life, and equitable access.
Medical technology industries can participate in the Cancer Mission through collaborative R&I projects.